SKI Market

A+| A| A-|

Indian Indices

Sensex

73,419.24 284.92
( 0.39%)

Global Indices

Nasdaq

46,577.55 215.03
(0.46%)

Dow Jones

6,594.89 45.37
(0.69%)

Hang Seng

52,384.74 -1,354.94
(-2.52%)

Nikkei 225

10,364.79 188.34
(1.85%)

Forex

USD-INR

93.85 -0.46
(-0.49%)

EUR-INR

107.97 -0.33
(-0.30%)

GBP-INR

124.03 -0.65
(-0.52%)

JPY-INR

0.59 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indraprastha Gas Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

532514

INE203G01027

70.0163508

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IGL

14.44

20741.02

EPS(TTM)

Face Value()

Div & Yield %

10.26

4.72

Back

Natco Pharma receives CDSCO approval for launch of Semaglutide in India

Feb 14,2026

Natco Pharma received approval for Semaglutide from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India. NATCO will launch the product in the India market in March'26.

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

73,419.24 284.92 ( 0.39%)

46,577.55 215.03 (0.46%)

6,594.89 45.37 (0.69%)

52,384.74 -1,354.94 (-2.52%)

10,364.79 188.34 (1.85%)

93.85 -0.46 (-0.49%)

107.97 -0.33 (-0.30%)

124.03 -0.65 (-0.52%)

0.59 0.00 (-0.26%)